Evidence map›Paper›PMID 28808028›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Immune evasion by a staphylococcal inhibitor of myeloperoxidase.

Nienke W M de Jong, Kasra X Ramyar, Fermin E Guerra, Reindert Nijland, Cindy Fevre, Jovanka M Voyich, Alex J McCarthy, Brandon L Garcia, Kok P M van Kessel, Jos A G van Strijp and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Methicillin-resistantiScience · 2026
    Review
  3. Journal of bacteriology · 2025
    Review
  4. Review
  5. Article
  6. Pathogens (Basel, Switzerland) · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Human neutrophilsImmunological reviews · 2023
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Nienke W M de JongMedical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Kasra X RamyarDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, KS 66506.
Fermin E GuerraDepartment of Microbiology and Immunology, Montana State University, Bozeman, MT 59717.
Reindert NijlandMedical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.ORCID 0000-0003-0049-3768
Cindy FevreMedical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Jovanka M VoyichDepartment of Microbiology and Immunology, Montana State University, Bozeman, MT 59717.
Alex J McCarthyMedical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Brandon L GarciaDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, KS 66506.
Kok P M van KesselMedical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Jos A G van StrijpMedical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands; j.vanstrijp@umcutrecht.nl.
Brian V GeisbrechtDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, KS 66506.
Pieter-Jan A HaasMedical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
University Medical Center Utrecht · NLKansas State University · USMontana State University · US

Funding

VIRUSES: FROM PARTICLES TO PROTEOMICSP20RR020185 · NCRR · MONTANA STATE UNIVERSITY - BOZEMAN · PI QUINN, MARK T · 2004 to 2011
$17.0M
Novel Staphylococcal Inhibitors of Neutrophil Granule EnzymesR01GM121511 · NIGMS · KANSAS STATE UNIVERSITY · PI GEISBRECHT, BRIAN V · 2017 to 2020
$1.2M
Inhibition of the Classical & Lectin Complement Pathways by Staphylococcus aureus EapR21AI111203 · NIAID · KANSAS STATE UNIVERSITY · PI GEISBRECHT, BRIAN V · 2015 to 2016
$375k
NCRR NIH HHS P20 RR020185NIAID NIH HHS R21 AI111203NIGMS NIH HHS R01 GM121511
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bacterial ProteinsGene Expression Regulation, BacterialHumansModels, MolecularNeutrophilsPeroxidasePhagocytosisProtein BindingProtein ConformationStaphylococcus aureusUp-RegulationBacterial ProteinsPeroxidaseimmune evasionmyeloperoxidaseneutrophilphagocytosisStaphylococcus aureus

Identifiers

PMID28808028
PMCPMC5584439
OpenAlexW2749218713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.